ACCORD study: a national multi-centre study of the watch and wait approach in patients with rectal cancer in Aotearoa New Zealand
- PMID: 40071714
- DOI: 10.1111/ans.19415
ACCORD study: a national multi-centre study of the watch and wait approach in patients with rectal cancer in Aotearoa New Zealand
Abstract
Aim: The adoption of a watch and wait (W&W) approach in patients with rectal cancer, and a complete clinical response (cCR) following neoadjuvant therapy, is increasing worldwide. Despite this, pragmatic unbiased outcome data is limited. This study aimed to investigate national outcomes associated with W&W in Aotearoa New Zealand (AoNZ).
Methods: A national retrospective study of patients with adenocarcinoma of the rectum managed with a W&W approach between January 2015 and December 2022 in AoNZ was performed by STRATA, a student and trainee led collaborative network. The Cancer Registry and the New Zealand Ministry of Health National Minimum Data Set were linked to identify patients who had rectal cancer and who were treated with neoadjuvant therapy but not rectal resection. Research teams across 17 AoNZ hospitals then screened these patients for inclusion and data collection.
Results: One thousand five hundred and eighteen patients were screened across 17 hospitals, 133 met inclusion criteria. Median age was 71 years. Median follow-up was 2.2 years. The 2-year cumulative incidence of local regrowth was 18.2% (95% CI 10.7%-25.1%), of which 92% was present in the bowel wall, and 68% underwent surgery, all with curative intent. The 2-year cumulative distant metastasis rate was 8.8% (95% CI 3.0%-14.2%) and the 2-year overall survival was 94.8% (95% CI 90.4%-99.4%).
Conclusion: This nationwide study of a W&W approach has clinical outcomes similar to the international literature. This data will help guide further implementation of a W&W approach in the management of patients with rectal cancer and inform both clinicians and patients.
Keywords: colo; colorectal surgery; rectal cancer; surgical oncology; watch and wait.
© 2025 Royal Australasian College of Surgeons.
References
-
- Araghi M, Soerjomataram I, Jenkins M et al. Global trends in colorectal cancer mortality: projections to the year 2035. Int. J. Cancer 2019; 144: 2992–3000.
-
- Waddell O, Pearson J, McCombie A et al. The incidence of early onset colorectal cancer in Aotearoa New Zealand: 2000‐2020. BMC Cancer 2024; 24: 456.
-
- Jackson C, Ehrenberg N, Frizelle F et al. Rectal cancer: future directions and priorities for treatment, research and policy in New Zealand. N. Z. Med. J. 2014; 127: 63–72.
-
- Stockton JD, Tee L, Whalley C et al. Complete response to neoadjuvant chemoradiotherapy in rectal cancer is associated with RAS/AKT mutations and high tumour mutational burden. Radiat. Oncol. 2021; 16: 129.
-
- Dossa F, Chesney TR, Acuna SA, Baxter NN. A watch‐and‐wait approach for locally advanced rectal cancer after a clinical complete response following neoadjuvant chemoradiation: a systematic review and meta‐analysis. Lancet Gastroenterol. Hepatol. 2017; 2: 501–513.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Miscellaneous
